Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Amortization of Deferred Charges (2019 - 2021)

Historic Amortization of Deferred Charges for Biodesix (BDSX) over the last 3 years, with Q1 2021 value amounting to $41000.0.

  • Biodesix's Amortization of Deferred Charges rose 1388.89% to $41000.0 in Q1 2021 from the same period last year, while for Mar 2021 it was $147000.0, marking a year-over-year change of. This contributed to the annual value of $144000.0 for FY2020, which is 0.0% changed from last year.
  • As of Q1 2021, Biodesix's Amortization of Deferred Charges stood at $41000.0, which was up 1388.89% from $35000.0 recorded in Q4 2020.
  • In the past 5 years, Biodesix's Amortization of Deferred Charges ranged from a high of $41000.0 in Q1 2021 and a low of $35000.0 during Q4 2019
  • Moreover, its 3-year median value for Amortization of Deferred Charges was $35500.0 (2019), whereas its average is $36750.0.
  • Its Amortization of Deferred Charges has fluctuated over the past 5 years, first changed by 0.0% in 2020, then soared by 1388.89% in 2021.
  • Quarter analysis of 3 years shows Biodesix's Amortization of Deferred Charges stood at $35000.0 in 2019, then changed by 0.0% to $35000.0 in 2020, then rose by 17.14% to $41000.0 in 2021.
  • Its Amortization of Deferred Charges stands at $41000.0 for Q1 2021, versus $35000.0 for Q4 2020 and $36000.0 for Q1 2020.